The RSB Show 3-19-23 – No Antibiotics? No Problem, but World Health Organization pushes more, FDA Approves Fourth COVID Shot for infants, and German Health Minister Reverses Course on COVID Vaccine Injuries

March 19th, 2023 1-2PM ET

Sunday on The Robert Scott Bell Show:

‘Simply Obscene’: FDA Approves Fourth COVID Shot for Infants and Kids Under 5 The U.S. Food and Drug Administration’s decision Tuesday to allow infants and children 6 months through age 4 to get Pfizer’s bivalent booster shot drew harsh criticism from pediatricians and others who said children don’t need any COVID-19 vaccines, let alone four doses. Infants and children 6 months through age 4 who received the three-dose primary series of the Pfizer-BioNTech COVID-19 vaccine are now eligible for a fourth dose — Pfizer’s bivalent booster shot. The U.S. Food and Drug Administration (FDA) on Tuesday amended the Emergency Use Authorization (EUA) of Pfizer bivalent COVID-19 booster vaccine for the younger age group, but only for those children who received the three-dose series before the FDA authorized Pfizer’s bivalent Omicron booster as the third shot in the primary series. Under the amended authorization, children can receive their fourth shot two months after completing the three-dose primary series. Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research, said the authorization gave parents the opportunity to “update their children’s protection.” But critics including Peter McCullough, M.D., MPH, an internist and cardiologist, said the shots pose long-term safety concerns for children. “I am greatly concerned about the long-term safety of accumulating novel mRNA and Wuhan spike protein in previously healthy children,” McCullough told The Defender. “Continued shots are not natural and cannot make their bodies healthier.”

German Health Minister Reverses Course on COVID Vaccine Injuries, Says Injured Being Ignored Germany’s Federal Minister of Health Karl Lauterbach — a former Harvard University adjunct professor — this week admitted that COVID-19 vaccine adverse events are prevalent and that those suffering from severe vaccine injuries are being ignored. Germany’s Federal Minister of Health Karl Lauterbach — a former adjunct professor at Harvard University — this week admitted that COVID-19 vaccine adverse events are prevalent and that those suffering from severe vaccine injuries are being ignored. Lauterbach, one of Germany’s foremost voices in favor of strict COVID-19 restrictions and vaccine mandates, made the comments in a March 12 interview on ZDF, Germany’s national public television broadcaster. As recently as February 2022, Lauterbach claimed COVID-19 vaccines are free of side effects. Lauterbach’s admission came amid allegations he previously falsified his academic credentials. 1 in 10,000 incidence of severe adverse events from COVID vaccines During the interview on ZDF’s “Heute Journal,” Lauterbach admitted the incidence of severe adverse events from the COVID-19 vaccines was 1 in 10,000 people. He said: “According to the latest research data, severe vaccine injuries are very rare. The incidence is less than 1:10,000 vaccinations. “I’ve always been aware of the numbers. They have remained relatively stable. … 1:10,000: some may say that’s a lot, and some may say it’s not that much.” Despite describing the incidence of severe adverse effects as “very rare,” Lauterbach backtracked on earlier claims that the COVID-19 vaccines did not cause side effects. On Aug. 14, 2021, Lauterbach tweeted that the COVID-19 vaccines had “no side effects.” ZDF journalist Christian Sievers confronted Lauterbach on his previous claims, stating, “You’ve always given the impression that side effects aren’t really a thing.”

Too few antibiotics in pipeline, World Health Organization review warns A new analysis of of antibiotics being developed shows that too few are in the pipeline, particularly those needed to target potentially dangerous pathogens. The update on the landscape for new antibiotics was published online Wednesday in advance of the European Congress of Clinical Microbiology & Infectious Diseases in Copenhagen, Denmark, that runs from April 15 to 18. The review from WHO shows that just 12 new antibiotic shave entered the market over the five-year period from 2017 to 2021. There are 27 under development in clinical trials against pathogens considered “critical,” such as Acinetobacter baumannii and Pseudomonas aeruginosa. Of these 27 under development, only six are considered ‘innovative’ enough to be capable of overcoming antibiotic resistance. Two of the six are targeting highly drug resistant forms of microbes. “In the five years covered by this report, we have had just 12 antibiotics approved, with only one of these — Cefiderocol — able to target all the pathogens deemed critical by WHO,” Dr. Valeria Gigante said in a statement. “And there are only 27 more currently under development in phase 1 to 3 clinical trials, with little innovation. Only four of the 27 have new mechanisms of action, and most are not new drug classes, but the evolution of existing classes,” said Gigante, the team lead in the World Health Organization’s Antimicrobial Resistance Division in Geneva, Switzerland. Researchers said one antibiotic, Solithroymcin, can be used to treat community-acquired pneumonia and other infections. It is in the new drug application stage, meaning it passed through clinical trials and awaiting market authorization. Seven other antibiotics are in phase 3 trials, having their efficacy assessed.

Remember Friends, The Power to Heal is Yours!